Jabasa, Baby Boy .

HRN: 28-15-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
11/30/2025
PO
2ml
BID
PCAP
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiricEmpirical De-escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: